Johnson & Johnson Q2 Earnings Beat Analysts’ Estimates – ValueWalk Premium
Johnson & Johnson

Johnson & Johnson Q2 Earnings Beat Analysts’ Estimates

This morning saw the release of an earnings report from Johnson & Johnson (NYSE:JNJ). The consumer goods and health care products firm showed earnings of $1.48 per share for the three months ending June 30, on revenue of $17.9 billion for the period. Shares in Johnson & Johnson will open at $90.40 later this morning.

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0